Spero Therapeutics (SPRO) Share-based Compensation (2016 - 2026)
Spero Therapeutics (SPRO) reported Share-based Compensation of $822,000 for Q2 2026, up 15.1% from $714,000 a year earlier but down 26.2% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Share-based Compensation (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Spero Therapeutics' Share-based Compensation came in at $3.99 million, down 32.7% year-over-year; for FY2025, it was $4.33 million, down 44.5% from FY2024.
- Share-based Compensation has declined for four consecutive years, with a five-year compound annual growth rate of -2.4% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $7.79 million in FY2024 (-1.8%), $7.93 million in FY2023 (-13.1%), $9.12 million in FY2022 (-3.3%) and $9.43 million in FY2021 (+92.9%).
- Five-year quarterly Share-based Compensation spans a low of $714,000 in Q2 2025 and a high of $3.2 million in Q1 2022.
- Year over year, Share-based Compensation gained in two of the last eight quarters, with an average decline of 24.8%.
- The high point for year-over-year Share-based Compensation in five years was Q4 2021 (growth of 114.5%); the low point was Q2 2025 (a decline of 66.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.11 million (Q1 2026), $1.01 million (Q4 2025) and $1.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.42 Bn | 1,106.00 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 617.98 Bn | 536.51 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 502.80 Bn | 475.92 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 368.67 Bn | 323.05 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.36 Bn | 262.35 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.17 Bn | 234.85 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.18 Bn | 192.58 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.11 Bn | 165.31 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Spero Therapeutics | 67.82 Mn | -127.96 Mn | - | 822,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 822,000.00 |
| Mar 31, 2026 | 1.11 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 714,000.00 |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 2.11 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 3.20 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Sep 30, 2021 | 2.33 Mn |
API Access
Spero Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();